SBIR Is Back, but the Gatekeepers Got Bigger

I was parked in the quiet end of a public library, where the carpet swallows footsteps and civic promises sit in hardback, when the update arrived the modern way: not with a parade, but with a filing. The federal small-business innovation spigot is officially back on.

What happened: SBIR and STTR extended through 2031

On April 13, 2026, the White House announced the President signed S. 3971, the Small Business Innovation and Economic Security Act. The law authorizes, through fiscal year 2031, and amends the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs and related pilots.

Congress moved it earlier this spring. The Senate cleared it by voice vote on March 3, 2026, and the House approved it on March 17, 2026 by a vote of 345 to 41 (per the International Economic Development Council summary). The programs had expired on September 30, 2025, and small businesses tend to run on calendars and payrolls, not congressional vibes.

What changed: longer runway, bigger bets, thicker screening

• Predictability returns. Authorities extend out to September 30, 2031, giving agencies room to plan solicitations and firms room to plan beyond the next quarter.
• A new “strategic breakthrough” lane. For certain agencies, a slice of SBIR funding can support awards up to $30,000,000, with performance periods up to 48 months, and with matching funds requirements.
• A sharper security gate. The law directs agencies to evaluate whether a small business presents a security risk, using due diligence, disclosures, and coordination with the intelligence community and federal law enforcement. It also ties denial decisions to existing government lists and contemplates denials where the primary source is classified.

The Paine test

Does this expand liberty, or concentrate power? Reauthorization expands practical liberty by keeping an on-ramp open for smaller firms in a world otherwise dominated by incumbents with compliance machines and lobbyists on speed dial. But it also concentrates gatekeeping inside agencies, including denial pathways that can hinge on information the applicant may not be able to see or meaningfully contest. I am not allergic to national security. I am allergic to unreviewable national security.

The Orwell check

Watch the euphemisms. Here it is “research security,” which can mean protecting labs from theft, or quietly locking competitors out. When decisions turn on lists, affiliations, and undisclosed sources, the line between legitimate counterintelligence and convenient exclusion gets thin, fast.

The liberty ledger (and the tradeoff)

Plus: firms get a planning horizon through 2031; agencies get tools to place bigger bets; matching funds signal market interest. Minus: entrepreneurs face new hoops that can be opaque or inconsistent; ordinary global ties can be treated as risk categories; and the $30 million world is simply easier for the well-networked and well-capitalized. That tradeoff might be worth it, but it needs daylight.

Guardrails worth adding before the next midnight hearing

If security risk is cited, Congress and agencies should insist on clear, appealable denial pathways even when underlying intelligence cannot be fully disclosed. They should also publish sunlight metrics: how many applications are denied for security reasons, how often lists are implicated, which agencies deny at higher rates, and how long reviews take. And they should treat “capture” as a live risk, especially with loud support from the U.S. Chamber of Commerce. Small business cannot mean small circle.

The law is signed. Now comes the part where inspectors general, auditors, committees, and watchdogs earn their keep: if innovation becomes a security checkpoint, who is watching the watchlist, and what happens to the small business flagged with no meaningful way to clear its name?